Zacks Investment Research on MSN

ANIP vs. TEVA: Which drug stock is the better buy right now?

Both ANI Pharmaceuticals ANIP and Teva Pharmaceuticals TEVA operate in the pharmaceutical sector, focusing on generic and ...
Zacks Investment Research on MSN

FOLD rises 136% in 6 months: Should you buy, sell or hold the stock?

Shares of Amicus Therapeutics FOLD have witnessed a strong surge in the past six months, primarily driven by the growing ...

US Supreme Court to hear 'skinny label' patent fight involving Amarin

The U. Supreme Court agreed on Friday to hear a patent dispute involving Amarin Pharma's cardiovascular drug Vascepa that ...
STAT

Supreme Court agrees to review ‘skinny labeling’ and generic drug access

The Supreme Court agreed to review a controversy over so-called skinny labels for medicines, a decision that will be closely ...

Justices to Consider Patent Case on ‘Skinny’ Drug Labels (1)

The US Supreme Court will hear generic drug maker Hikma Pharmaceuticals USA Inc.'s challenge of an appeals court holding that ...
The American Bazaar

Has Trump’s promise of more jobs fallen short so far?

President Donald Trump’s lofty promises about more jobs for Americans seems to have fallen flat. Reportedly, manufacturing ...